About: Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives
Creator	Pagliusi, Sonia Jarrett, Stephen Yang, Lingjiang
source	Medline; PMC
abstract	Manufacturers have a significant stake in the vaccine supply chain as their reputations rest on the effectiveness of their vaccines at the point of vaccination. The risks of low performing supply chains are detrimental for the safety and effectiveness of vaccines, with potential consequences to future supply in the case of adverse events. For this reason, a study was set up to explore the involvement of developing country manufacturers in the vaccine supply chain over the next decade to determine the areas where innovations could have a positive impact on the supply chain, focusing on the secondary stages of production where formulation, filling and packaging take place. An expert desk review identified eight areas of interest for the vaccine supply chain and informed the development of a survey to assess the relevance of the areas identified. The review also conjectured whether the overall effect of the identified areas is cost-neutral or resulting in net savings to countries. Overall, respondents identified five areas as of highest interest and subsequently an expert working group of representative manufacturers prioritized three of them. Specifically, traceability in the context of global digital health initiatives, stockpiling in the context of addressing vaccine shortages, stock-outs, outbreaks and epidemic prevention, and new packaging technologies are discussed in this report. It is important that vaccine manufacturers be actively engaged in global stakeholders' forums, as equal partners in determining the best ways for improving the vaccine supply chain.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.1016/j.jvacx.2020.100068
bibo:pmid	32775997
has license	cc-by
sha1sum (hex)	e5e0021c0abadeabad5023e4e5e4bbe987d8dff0
schema:url	https://doi.org/10.1016/j.jvacx.2020.100068
resource representing a document's title	Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives
has PubMed Central identifier	PMC7394771
has PubMed identifier	32775997
schema:publication	Vaccine X
resource representing a document's body	covid:e5e0021c0abadeabad5023e4e5e4bbe987d8dff0#body_text
is schema:about of	named entity 'equal' named entity 'areas' named entity 'risks' named entity 'stakeholders' named entity 'determining' named entity 'Manufacturers' named entity 'areas' named entity 'REST' named entity 'EPIDEMIC' named entity 'VACCINE' named entity 'CONTEXT' named entity 'ASSESS' named entity 'IMPORTANT' named entity 'NEW' named entity 'WORKING GROUP' named entity 'COUNTRIES' named entity 'desk' named entity 'innovations' named entity 'technologies' named entity 'secondary' named entity 'engaged' named entity 'vaccine' named entity 'expert' named entity 'adverse events' named entity 'detrimental' named entity 'packaging' named entity 'digital health' named entity 'impact' named entity 'context' named entity 'point' named entity 'Manufacturers' named entity 'emerging countries' named entity 'supply chain' named entity 'developing country' named entity 'vaccines' named entity 'epidemic' named entity 'supply chain' named entity 'vaccine' named entity 'supply chain' named entity 'supply chain' named entity 'supply chain' named entity 'vaccine' named entity 'vaccine' named entity 'vaccine' named entity 'distribution chains' named entity 'rubella' named entity 'vaccine' named entity 'chikungunya' named entity 'BFS' named entity 'health systems strengthening' named entity 'audit' named entity 'vaccination' named entity 'immunization' named entity 'vaccine' named entity 'quantitative data' named entity 'Vaccine' named entity 'vaccine' named entity 'human resources' named entity 'digital health' named entity 'virtuous cycle' named entity 'developing countries' named entity 'heat stability' named entity 'telecommunications' named entity 'supply chain' named entity 'supply chain' named entity 'cholera' named entity 'GS1' named entity 'Vaccine' named entity 'vaccine' named entity 'Ebola vaccine' named entity 'neonatal' named entity 'cholera' named entity 'cold chain' named entity 'vaccine' named entity 'WHO' named entity 'rotavirus' named entity 'vaccine' named entity 'price pressure' named entity 'hepatitis B vaccines'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software